Back
Speaker illustration

Doctor Seung-Jae Joo

Jeju National University Hospital, Jeju (Korea (Republic of))

Member of:

European Society of Cardiology

Seung-Jae Joo, MD, PhD, FESC is a professor of Jeju National University College of Medicine, and a cardiology specialist of Jeju National University Hospital in South Korea. He was the Director of Jeju Regional Center for Cardiocerebrovascular Diseases, the Dean of Jeju National University School of Medicine, and the President of Jeju National University Hospital in South Korea. As a qualified specialist of echocardiographic imaging, cardiovascular intervention, and critical care medicine, his main activities focus on the clinical care and research about patients with coronary artery diseases, heart failure, and hypertension. His basic research interest lies on the integrin system of platelets and vascular smooth muscle cells.

Presentations Articles

The clinical impact of improved or decreased left ventricular systolic function after the initial attack in patients with acute myocardial infarction

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure patient profile and outcome 1

Access
Like
Thumbnail

Association of beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mid-range left ventricular ejection fraction after acute myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Access
Like
Thumbnail

Angiotensin receptor blockers, compared with angiotensin-converting enzyme inhibitors, increased recurrent myocardial infarction in hypertensive patients with acute myocardial infarction

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

Access
Like
Thumbnail

Association between six-month blood pressure level and 1-year heart failure in hypertensive patients with acute myocardial infarction

Event: Heart Failure 2018

Topic: Hypertension, Other

Session: Hypertension - Other

Access
Like
Thumbnail

Beta-blockers in patients with preserved left ventricular systolic function after acute myocardial infarction did not improve clinical outcomes

Event: ESC Congress 2017

Topic: Adjunctive medical therapy

Session: Beta-blockers in acute coronary syndromes: the end of a dogma?

Access
Like
Thumbnail

Anticoagulation in patients with acute myocardial infarction who were presenting with atrial fibrillation improved clinical outcomes

Event: ESC Congress 2016

Topic: Thrombosis and coagulation

Session: Thrombosis and antithrombotic in acute coronary syndrome

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources